Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Land & Improvements: 2010-2023

Historic Land & Improvements for China Pharma Holdings (CPHI) over the last 12 years, with Jun 2023 value amounting to $389,808.

  • China Pharma Holdings' Land & Improvements fell 7.12% to $389,808 in Q2 2023 from the same period last year, while for Jun 2023 it was $389,808, marking a year-over-year decrease of 7.12%. This contributed to the annual value of $404,427 for FY2022, which is 8.46% down from last year.
  • According to the latest figures from Q2 2023, China Pharma Holdings' Land & Improvements is $389,808, which was down 4.90% from $409,895 recorded in Q1 2023.
  • Over the past 5 years, China Pharma Holdings' Land & Improvements peaked at $443,697 during Q1 2022, and registered a low of $389,808 during Q2 2023.
  • Over the past 3 years, China Pharma Holdings' median Land & Improvements value was $419,685 (recorded in 2022), while the average stood at $419,594.
  • In the last 5 years, China Pharma Holdings' Land & Improvements increased by 9.59% in 2021 and then fell by 8.65% in 2022.
  • China Pharma Holdings' Land & Improvements (Quarterly) stood at $403,755 in 2019, then climbed by 6.92% to $431,681 in 2020, then climbed by 2.34% to $441,783 in 2021, then dropped by 8.46% to $404,427 in 2022, then dropped by 7.12% to $389,808 in 2023.
  • Its last three reported values are $389,808 in Q2 2023, $409,895 for Q1 2023, and $404,427 during Q4 2022.